THESEUS PHARMACEUTICALS, INC. Operating Lease Right-of-Use Assets
THESEUS PHARMACEUTICALS, INC. had Operating Lease Right-of-Use Assets of $3.92 million as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2023-11-17
- 2023-09-30: Operating Lease, Right-of-Use Asset $3.92M.
- 2023-06-30: Operating Lease, Right-of-Use Asset $4.06M.
- 2023-03-31: Operating Lease, Right-of-Use Asset $4.20M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $4.33M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2023-09-30 | $3.92M 10-Q · filed 2023-11-17 |
| 2023-06-30 | $4.06M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $4.20M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $4.33M 10-Q · filed 2023-11-17 |
| 2022-09-30 | $4.46M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.60M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.72M 10-Q · filed 2022-05-12 |
| 2021-09-16 | $4.70M 10-K · filed 2023-03-09 |